HomeCompareDNDT vs EQR

DNDT vs EQR: Dividend Comparison 2026

DNDT yields 3333.33% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DNDT wins by $1244041712890.36M in total portfolio value
10 years
DNDT
DNDT
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full DNDT calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — DNDT vs EQR

📍 DNDT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDNDTEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DNDT + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DNDT pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DNDT
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, DNDT beats the other by $998,508,911,161,144,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DNDT + EQR for your $10,000?

DNDT: 50%EQR: 50%
100% EQR50/50100% DNDT
Portfolio after 10yr
$622020856445.22M
Annual income
$587,358,183,035,971,000.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

DNDT
No analyst data
Altman Z
-338.5
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DNDT buys
0
EQR buys
0
No recent congressional trades found for DNDT or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDNDTEQR
Forward yield3333.33%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1244041712890.40M$40.5K
Annual income after 10y$1,174,716,366,071,938,000.00$3,819.61
Total dividends collected$1239274250481.68M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DNDT vs EQR ($10,000, DRIP)

YearDNDT PortfolioDNDT Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$344,033$333,333.33$11,248$547.57+$332.8KDNDT
2$11,085,665$10,717,549.33$12,701$666.53+$11.07MDNDT
3$334,616,633$322,754,971.08$14,405$814.59+$334.60MDNDT
4$9,462,934,690$9,104,894,892.71$16,413$999.84+$9462.92MDNDT
5$250,766,259,005$240,640,918,887.41$18,795$1,232.92+$250766.24MDNDT
6$6,228,082,462,189$5,959,762,565,053.11$21,639$1,527.95+$6228082.44MDNDT
7$144,998,525,500,125$138,334,477,265,582.72$25,057$1,903.80+$144998525.48MDNDT
8$3,165,074,899,913,431$3,009,926,477,628,297.00$29,197$2,385.87+$3165074899.88MDNDT
9$64,790,043,755,570,470$61,403,413,612,663,110.00$34,250$3,008.70+$64790043755.54MDNDT
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$40,467$3,819.61+$1244041712890.36MDNDT

DNDT vs EQR: Complete Analysis 2026

DNDTStock

DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.

Full DNDT Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this DNDT vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DNDT vs SCHDDNDT vs JEPIDNDT vs ODNDT vs KODNDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.